5 Tips for Successful Decentralized Clinical Trials

Decentralized clinical trials (DCTs) –trials that don’t take place exclusively at major sites–have quickly grown in popularity. 89% of sponsors use DCT methods in some of their studies, and so do...

4 Trends in Clinical Research You Need to Know About from ACRP 2022

Wondering what’s next in the world of clinical research? Catherine Gregor, Florence’s Chief Clinical Trial Officer and the former Director of Clinical Research Administration at Vanderbilt,...

Why Sites Must Own the eISF

Tell me if this sounds familiar: a sponsor needs remote access to their sites, so they buy electronic Investigator Site Files (eISFs) and distribute them to their sites. Now the sponsor has...

6 Events You Won’t Want to Miss at ACRP 2022

How Digital Connections Can Create a Positive Patient Experience in Clinical Trials

Patient experience in clinical trials is a problem. On patient satisfaction surveys, clinical trials received low scores similar to the scores of Internet service providers, utility companies, and...

How the New EU Clinical Trials Regulation Will Impact Sites and Sponsors

The Clinical Trials Regulation (CTR) for the EU took effect on 31 January 2022. Sites and sponsors must now embrace the new regulations to successfully run clinical trials across the European...

Why Sponsors and CROs Are Investing in Electronic Investigator Site Files for Their Sites in 2022

The first three months of 2022 have seen a 3x uptick over the first three months of 2021 in clinical trial sponsors and CROs contacting Florence about deploying Electronic Investigator Site Files...

Decentralization of Clinical Trials Requires Digitization of Clinical Trials

Is the Industry Wired for This Revolution? You are almost guaranteed to have heard or seen the word "decentralized" in the last year if you've been to a clinical research conference, looked at...

How Community-Based Clinical Trials Benefit Sponsors, Local Healthcare Systems, and Patients

Clinical trials could help far more patients than they currently do. So how do we expand studies to all of the patients who need them? Community-based clinical trials might be the answer.  70% of...

What do the proposed changes to UK clinical trial regulations mean for you?

by Taylor Davidson, Content Writer With special thanks to Sara Guyler, Global Regulatory Specialist After leaving the European Union, the United Kingdom passed the Medicines and Medical Devices...

Clinical Trial Diversity: Lessons Learned from a Pandemic

Sites and sponsors struggled with clinical trial diversity long before the COVID-19 pandemic began. Roughly 20% of new drugs have different effects depending on a person’s race. This makes it...

4 Key Takeaways for Sponsors and CROs from “Digitizing the Site Network”–A Fireside Chat

by Blake Adams, SVP of Marketing at Florence Missed our fireside chat about how sponsors can work remotely with sites in traditional and decentralized trials? The recording with Nimita Limaye,...

Remote Trial Site Monitoring Is Permanent. Now What?

If you listen, you can hear it across the industry: the job of the Clinical Research Associate (CRA) and the business of the Contract Research Organization (CRO) have permanently changed. ...

New Year, New You? Using Change Management for Digital Clinical Trial Transformations

By Rachelle Stover, MPH, CCMP With the start of a new year, both people and organizations begin thinking about change. Perhaps there’s a new technology or software your clinical trial organization...

FAQ for the FDA’s New Guidance on Digital Health Technologies

89% of sponsors now embrace decentralized clinical trials (DCTs). With DCTs becoming commonplace, sites, sponsors and CROs have turned to the FDA for guidance on how to use clinical trial...